SSR2 and cancer: The involved cancers and genes for these 14 DESPGs are Uterine Corpus Endometrial Carcinoma (UCEC) (e.g., GLB1, HSPA5, and PDIA3), KIRC (e.g., FUT11, GNRH1 and IFNGR2), Liver hepatocellular carcinoma (LIHC) (e.g., BGLAP and SSR2), Kidney renal papillary cell carcinoma (KIRP) (e.g., ADAM9 and TPST2), Thyroid carcinoma (THCA) (e.g., TGFBR1), LUAD (e.g., TAC4), Kidney Chromophobe (KICH) (e.g., BSG), and COAD (e.g., FUCA1) (see Supplementary Figure 3).